Skip to content
Open access

Evaluation of the relationship between the SCORE2-diabetes mellitus cardiovascular risk score, degree of obesity, and systemic inflammatory indices in patients with type 2 diabetes mellitus

Oct 2026 · İstanbul Kuzey Klinikleri · Vol 13, pp. 551-557 · 0 citations · 24 references

TL;DR

This study evaluated the relationship between the SCORE2 diabetes mellitus cardiovascular risk score, obesity status, clinical and laboratory parameters, and hematologic systemic inflammatory indices in patients with type 2 diabetes mellitus (T2DM).

Abstract

OBJECTIVE: This study evaluated the relationship between the SCORE2 diabetes mellitus (SCORE2-DM) cardiovascular risk score, obesity status, clinical and laboratory parameters, and hematologic systemic inflammatory indices in patients with type 2 diabetes mellitus (T2DM)

Read PDF

Similar papers

Open access Oct 2026

Association between Continuous Glucose Monitoring and Risk of Acute Diabetes-Related Complications in Pediatric Type 1 Diabetes Mellitus: A Nationwide Cohort Study (Diabetes Metab J 2026 Apr 22 [Epub]. https://doi.org/10.4093/dmj.2025.0794).

between continuous glucose monitoring and risk of acute diabetes-related complications in pediatric

Ji Yon Kim, Seohyun Kim, Jae Hyeon Kim · 0 citations
Editorial Open access Oct 2026

Cardiovascular Diseases and Type 2 Diabetes: 2nd Edition

Diabetes mellitus (DM) is associated with multiple comorbidities, the most important being cardiovascular (CV) diseases (CVDs) and especially coronary artery disease (CAD), peripheral artery disease (PAD), stroke, and chronic kidney disease (CKD) [...].

C. Tudoran · 0 citations
Open access Oct 2026

Comparative associations of waist circumference and body-mass index with reduced kidney function in patients with type 2 diabetes mellitus

Aims: Central obesity may better reflect metabolic risk than general obesity in adults with type 2 diabetes mellitus (T2DM). This study compared the associations of waist circumference (WC) and body-mass index (BMI) with reduced kidney function.Methods: This retrospective, cross-sectional study included 300 adults with...

Aysun Şeker · 0 citations
Open access Sep 2026

Predicting the Long‐Term Risk of Type 2 Diabetes and Cardiovascular Disease With Orforglipron in People With Overweight or Obesity: A Post Hoc Analysis of the ATTAIN‐1 Trial

To assess change in long‐term predicted 10‐year cardiometabolic risk (Type 2 diabetes [T2D] and cardiovascular disease [CVD]) in adults with overweight or obesity without T2D.

S. Shinde, Florian Kahles, S. Vasileva-Metodiev et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.